Cystine-Skeleton Cationic Lipids for Intracellular Nucleic Acid Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing cationic lipids used for nucleic acid delivery face challenges in achieving high intracellular expression efficiency and stability, with a need for improved pharmacokinetics and intracellular dynamics to enhance delivery and reduce toxicity.
Innovation Solution
A cationic lipid with a cystine skeleton and disulfide bond is developed, allowing for adjustment of surface pKa and intracellular degradation, forming a lipid membrane structure that efficiently delivers nucleic acids into the cytoplasm.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If known cationic lipids (DOTAP, DODAP) are used to form positively-charged liposome structures, then nucleic acid delivery to target cells is achieved, but pharmacokinetics and intracellular expression efficiency are insufficient
Solution Approach 1:
The invention modifies the chemical structure of cationic lipids by introducing a cystine skeleton with disulfide bonds and adjusting the amine group structure. This changes the surface pKa of the lipid membrane structure, enabling it to remain positively charged at physiological pH for effective nucleic acid binding, while also improving intracellular dynamics and expression efficiency through controlled degradation.
Solution Approach 2:
The invention creates a composite lipid structure combining cystine backbone, lipid moieties, and amine groups. This composite structure integrates the benefits of cationic charge for nucleic acid complexation with the biodegradability of disulfide bonds, achieving both effective delivery and improved intracellular expression.
2Productivity
If cationic lipids are used as nucleic acid delivery carriers, then uptake into cells is promoted, but intracellular expression efficiency per unit lipid membrane structure remains low
Solution Approach 1:
The invention introduces disulfide bonds into the cationic lipid structure, making the lipid membrane structure dynamically degradable within cells. The disulfide bonds are cleaved by intracellular glutathione, causing the lipid structure to disassemble and release nucleic acids, thereby enhancing intracellular expression efficiency while maintaining good cell uptake.
3Stability of the object's composition
If lipid membrane structures are designed for high stability in blood, then pharmacokinetics are improved, but intracellular dynamics and endosome escape are hindered
Solution Approach 1:
The invention segments the lipid membrane structure into degradable components connected by disulfide bonds. This segmentation allows the structure to remain stable in blood circulation but to break apart into smaller components within the cell, facilitating endosome escape and intracellular release of nucleic acids.
4Adaptability or versatility
If multiple lipid types are available for selection, then treatment methods suitable for different diseases can be established, but the number of effective cationic lipid variants with optimized intracellular dynamics is limited
Solution Approach 1:
The invention creates a universal cationic lipid platform based on the cystine skeleton that can be adapted for different nucleic acid therapies. The core disulfide bond structure provides universal intracellular degradation capability, while variations in lipid moieties and amine groups can be tuned for specific disease applications, reducing the need for completely different lipid structures for each therapy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The cationic lipid enhances nucleic acid delivery efficiency by promoting intracellular release and reducing degradation in serum, improving intracellular dynamics and expression levels.
Implementation Method 1
the amine moiety showing cationicity and a polyanion nucleic acid electrostatically interact to form a liposome or lipid membrane structure
Implementation Method 2
the cationic lipid can improve intracellular dynamics by dissociating nucleic acid from a lipid membrane structure by utilizing intracellular cleavage of a disulfide bond
Data Source
AI summary
The present invention provides, a cationic lipid represented by the formula (1) (wherein each symbol is as defined in the specification), a lipid membrane structure using the aforementioned cationic lipid, a nucleic acid-introducing agent using the aforementioned cationic lipid, and a method for introducing a nucleic acid by using the aforementioned nucleic acid-introducing agent.